Form D · Biotechnology
Saladax Biomedical Inc
Bethlehem, PA · CIK 0001418094
Offering snapshot reported Sep 10, 2013 · SEC filing
- Reported sold
- $22.9M Offering amount: $22.9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2013 | Initial | $22,930,294 | No comparison | 7 | SEC filing |
| Oct 5, 2009 | Initial | $7,923,399 | No comparison | 62 | SEC filing |
| Aug 20, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-202644
Series D Preferred Stock
Source: Form D, filed Sep 10, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adrienne Choma | Director, Executive |
| Greg Critchfield | Director |
| Edward L. Erickson | Director |
| Joel Gross | Director |
| Kevin Harter | Director, Executive |
| James Hensel | Director |
| Enrico Petrillo | Director |
| Salvatore J. Salamone | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
116 Research Drive
Bethlehem, PA, 18015
Bethlehem, PA, 18015